BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10211085)

  • 21. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
    Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast conserving therapy in stage I & II breast cancer in Korea.
    Lee HD; Yoon DS; Koo JY; Suh CO; Jung WH; Oh KK
    Breast Cancer Res Treat; 1997 Jul; 44(3):193-9. PubMed ID: 9266098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.
    Osborne MP; Borgen PI; Wong GY; Rosen PP; McCormick B
    Surg Gynecol Obstet; 1992 Mar; 174(3):189-94. PubMed ID: 1542833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
    Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
    Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
    BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
    Willner J; Kiricuta IC; Kölbl O
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients.
    van Laar C; van der Sangen MJ; Poortmans PM; Nieuwenhuijzen GA; Roukema JA; Roumen RM; Tjan-Heijnen VC; Voogd AC
    Eur J Cancer; 2013 Oct; 49(15):3093-101. PubMed ID: 23800672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-five year results of the national cancer institute randomized breast conservation trial.
    Simone NL; Dan T; Shih J; Smith SL; Sciuto L; Lita E; Lippman ME; Glatstein E; Swain SM; Danforth DN; Camphausen K
    Breast Cancer Res Treat; 2012 Feb; 132(1):197-203. PubMed ID: 22113254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol.
    Blichert-Toft M; Nielsen M; Düring M; Møller S; Rank F; Overgaard M; Mouridsen HT
    Acta Oncol; 2008; 47(4):672-81. PubMed ID: 18465335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life of patients one year after breast-conserving surgery versus modified radical mastectomy for early breast cancer: a Kenyan tertiary hospital five-year review.
    Senoga A; Wasike R; Ali Mwanzi S; Mutebi M
    Pan Afr Med J; 2023; 46():69. PubMed ID: 38282779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone.
    Nguyen DV; Kim SW; Oh YT; Noh OK; Jung Y; Chun M; Yoon DS
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33947007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
    Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
    Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving therapy in breast cancer patients--a 12-year experience.
    Mannell A
    S Afr J Surg; 2005 May; 43(2):28-30; discussion 30, 32. PubMed ID: 16035379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.